drugset / Trial / NCT02155023

Feasibility Study to Determine the Optimal Calibration Method for Glucose Sensors

NCT02155023

NaSingle-groupOpen-labelBasic science

Summary

Two new glucose sensors (IR-Glucose Reader (Joanneum Research, Austria), IR-CGM (IMM, Germany)) will be investigated to determine the optimal calibration method in patients with type 1 diabetes

Timeline

Start
2014-01
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Background Insulin Lispro Protein / enzyme biologic
Background insulin aspart Protein / enzyme biologic
Background insulin detemir Protein / enzyme biologic
Background insulin glargine Protein / enzyme biologic

Indications